Global Strabismus Market, By Type (Esotropia, Exotropia, Hypertropia and Hypotropia), Treatment (Eyeglasses or Contact Lenses, Prism Lenses, Vision Therapy, Eye Drops, Botulinum Toxin and Eye Muscle Surgery), End-Users (Clinics, Hospitals, Homecare, Therapy Centres and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Strabismus Market
Strabismus market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 6.30% in the above-mentioned research forecast period. Increasing prevalence of eye disorders and rising cases of Down syndrome may drive the market growth.
Strabismus is also known as crossed eyes in which both the eyes lose its ability to look at the same position at the same time. It usually affects the people who have weakened eye muscle control. This disease has been reported to affect children and infants mostly at the age of 3 years but older children can also develop the disease symptoms. Strabismus is of four types based on the direction the eye turns including esotropia, exotropia, hypertropia, hypotropia. Strabismus can be transferred from affected parent to offspring, people who already have uncorrected farsightedness can also develop strabismus; moreover children suffering from Down syndrome are at higher risk of developing strabismus. Eyeglasses or contact lenses, prism lenses, vision therapy, eye drops, botulinum toxin and eye muscle surgery are some of the options indicated for strabismus treatment.
Moreover, increasing focus of market players towards the development of advanced treatment options and the presence of pipeline therapies also boost up the market growth. Furthermore increasing research and development and rising healthcare expenditure act as opportunities for the market growth. But, sometimes adverse effect related to the eye drops, strict regulatory framework and high cost of vision therapy among others may hamper the strabismus market.
This strabismus market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Strabismus Market Scope and Market Size
Strabismus market is segmented on the basis of type, treatment, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the strabismus market is segmented into esotropia, exotropia, hypertropia and hypotropia.
- On the basis of treatment, the strabismus market is segmented into eyeglasses or contact lenses, prism lenses, vision therapy, eye drops, botulinum toxin and eye muscle surgery.
- On the basis of end-users, the strabismus market is segmented into clinics, hospitals, homecare, therapy centres and others.
- On the basis of distribution channel, the strabismus market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others.
Strabismus Market Country Level Analysis
Strabismus market is analysed and market size information is provided by country, treatment, route of administration, end-users and distribution channel as referenced above.
The countries covered in the strabismus market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
On geographical estimation, North America accounts the largest market share due to the rising prevalence of Down syndrome with reported 1 in every 700 children in the U.S. Moreover, increasing governmental concern towards the children health and increasing research and development activities is also boosting the growth of market. Europe is expected to grow in strabismus market due to the increasing product distribution channel and rising market players’ initiatives. Asia-Pacific is expected to account for the largest market share owing to rising organizations initiatives to enhance the awareness towards the ophthalmic diseases.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Strabismus market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Strabismus Market Share Analysis
Strabismus market competitive landscape provides details by competitor details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to strabismus market.
The major players covered in the strabismus market are Essilor, AbbVie, BIOVENCER HEALTHCARE PRIVATE LIMITED, BIO-MED, Merz Pharma, Medytox, Metabiologics, AdvaCare Pharma, Accelius Global, Henry Schein, Inc, Bausch & Lomb Incorporated, Cirondrugs, Allergan, Galderma, Ipsen Pharma, Edmund Optics Inc., THE FRESNEL PRISM AND LENS CO., Optimax Systems, Inc., Smart Optometry, Vivid Vision, Inc., BYNOCS, Dynamic Center for Vision Therapy among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
